Sandoz: A Key Player in the Pharmaceutical Industry
Sandoz is a global leader in generic pharmaceuticals and biosimilars, serving millions of patients worldwide. Their mission is to make affordable, high-quality medicines available to more people, supporting healthcare systems and advancing patient care.
About Sandoz
Sandoz, part of the Novartis Group until 2023, has a long history of innovation and commitment to pharmaceutical quality. Today, Sandoz operates independently, focusing on both generic and biosimilar medicines.
Main Therapeutic Areas
Sandoz products cover a wide range of therapeutic areas to address diverse patient needs:
Antibiotics
Sandoz offers a broad selection of antibiotics, helping combat bacterial infections and improve public health outcomes.
Oncology
With a strong presence in cancer care, Sandoz provides essential medicines that support critical oncology treatments.
Biosimilars
Sandoz pioneers biosimilar medicines, providing more affordable alternatives to complex biologic drugs and making advanced therapies more accessible.
Commitment to Sustainability
Sandoz is committed to sustainable business practices, focusing on reducing their environmental footprint, promoting responsible supply chains, and supporting ethical standards throughout all operations.
Innovation and Research
Innovation remains at the heart of Sandoz’s strategy. The company continually invests in research and development to ensure a robust pipeline of new generic and biosimilar medicines.
Future Perspectives
With a global reach and a dedication to patient wellbeing, Sandoz is poised to remain a leader in pharmaceutical care for years to come, bringing quality medicines to those who need them most.